Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Taneja

Showing results (71-80 of 845) with videos related to

Pageof 85
Sort By:
The Journal of Urology|April 21, 2021
Urological Oncology: Prostate CancerSamir S Taneja
The Journal of Urology|January 18, 2019
Re: Olaparib Combined with Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 TrialSamir S Taneja
The Journal of Urology|September 22, 2020
Re: Facility-Level Variation in Pelvic Lymphadenectomy during Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate CancerSamir S Taneja
The Journal of Urology|December 25, 2015
Re: Tissue-Based Genomics Augments Post-Prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenSamir S Taneja
The Journal of Urology|February 9, 2016
Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)Samir S Taneja
The Journal of Urology|October 4, 2014
Re: cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH databaseSamir S Taneja
The Journal of Urology|September 19, 2015
Re: High-Dose Radiotherapy with Short-Term or Long-Term Androgen Deprivation in Localised Prostate Cancer (DART01/05 GICOR): A Randomised, Controlled, Phase 3 TrialSamir S Taneja
The Journal of Urology|July 19, 2014
Re: Clinical performance of serum isoform (-2)proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: results from a multicentric European studySamir S Taneja
The Journal of Urology|September 15, 2017
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 YearsSamir S Taneja
The Journal of Urology|December 20, 2014
Re: Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancerSamir S Taneja
Pageof 85

Showing results (71-80 of 845) with videos related to

Sort By:
Pageof 85
The Journal of Urology|April 21, 2021
Urological Oncology: Prostate CancerSamir S Taneja
The Journal of Urology|January 18, 2019
Re: Olaparib Combined with Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 TrialSamir S Taneja
The Journal of Urology|September 22, 2020
Re: Facility-Level Variation in Pelvic Lymphadenectomy during Radical Prostatectomy and Effect on Overall Survival in Men with High-Risk Prostate CancerSamir S Taneja
The Journal of Urology|December 25, 2015
Re: Tissue-Based Genomics Augments Post-Prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenSamir S Taneja
The Journal of Urology|February 9, 2016
Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)Samir S Taneja
The Journal of Urology|October 4, 2014
Re: cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH databaseSamir S Taneja
The Journal of Urology|September 19, 2015
Re: High-Dose Radiotherapy with Short-Term or Long-Term Androgen Deprivation in Localised Prostate Cancer (DART01/05 GICOR): A Randomised, Controlled, Phase 3 TrialSamir S Taneja
The Journal of Urology|July 19, 2014
Re: Clinical performance of serum isoform (-2)proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: results from a multicentric European studySamir S Taneja
The Journal of Urology|September 15, 2017
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 YearsSamir S Taneja
The Journal of Urology|December 20, 2014
Re: Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancerSamir S Taneja
Pageof 85